Skip to main content
Strategy documents

Ireland’s Cervical Cancer Elimination Action Plan 2025-2030

The actions we will take in Ireland from 2025 to 2030 to eliminate cervical cancer and make it a rare disease in every community by 2040.

What cervical cancer elimination means

The World Health Organization (WHO) defines cervical cancer elimination as fewer than 4 cases of cervical cancer per 100,000 women. Elimination does not mean there will be no cases of cervical cancer. It means cervical cancer will become rare and will no longer be a public health problem.

Ireland's cervical cancer incidence rate was 10.1 cases per 100,000 women in the preliminary data used to develop this action plan. Modelling using Irish data predicts that Ireland can reach elimination by 2040.

The WHO has set global targets for 2040 for HPV vaccination, cervical screening and treatment.

The WHO's targets for 2040 are:

  • 90% of girls vaccinated against HPV by age 50
  • 70% of women screened by age 35 and again by age 45
  • 90% of people identified with cervical disease treated.

Our targets for 2030

Ireland has set national targets for 2030 to build on the WHO targets to help us reach elimination by 2040.

We aim to:

  • increase HPV vaccination coverage to 90% of girls by age 15 (baseline rate was 84% in 2022)
  • increase HPV cervical screening coverage to 80% of eligible people screened every 5 years (baseline screening coverage was 73% in 2022)
  • maintain 97% treatment within 1 year for people diagnosed with cervical disease (baseline rate for treatment for invasive disease was 97%).

By 2030, we want all targets to be reached for all eligible people in every community.

Our strategic actions to eliminate cervical cancer

We have 9 strategic actions to achieve by 2030.

These include:

  • equity as a central priority
  • 3 service pillars (HPV vaccination, HPV cervical screening, and cervical pre-cancer and cervical cancer treatment)
  • 5 enabling areas (partnership and advocacy, communications, workforce and education, research, and data, monitoring and evaluation).

1. Equity

We will work to ensure that cervical cancer elimination is achieved across all population groups and that services respect people's cultures and needs.

We aim to:

  • work with priority populations to co-design, test and evaluate services and interventions that meet their needs
  • decide what equity data we need to collect and report
  • develop the systems needed to collect this data
  • use data to identify where inequalities exist and address them
  • introduce a new CervicalCheck register to collect better data and offer people more ways to take part.

2. HPV vaccination

We will increase the coverage rates of HPV vaccination by improving the delivery of the school-based vaccination programme. We will also make sure vaccination services are tailored to meet the needs of underserved populations

We aim to:

  • identify and address differences in HPV vaccination uptake
  • tailor vaccination services to underserved populations
  • improve how vaccination coverage is measured and reported
  • give children who miss their school vaccination visit another opportunity to get the HPV vaccine during first year of secondary school
  • provide HPV vaccine information and support in the community for undeserved groups.

3. HPV cervical screening

We will continue to review national and international research so that CervicalCheck continues to deliver a modern, research-led and effective screening programme.

We aim to:

  • review the evidence on introducing self-sampling for cervical screening
  • study whether self-sampling could be introduced in Ireland
  • assess options for referring people with HPV to colposcopy
  • look for opportunities to expand access to screening including co-designing community interventions with underserved populations
  • continue plans for a new cervical screening register
  • consider how new technology could improve how we invite people for screening and how results are managed and reported.

4. Cervical pre-cancer and cervical cancer treatment

We will improve how services work together to support the diagnosis and treatment of cervical pre-cancer and cervical cancer.

We aim to:

  • look for ways to improve how services work together across the cervical cancer pathway'
  • develop GP referral guidance for people with suspected gynaecological cancer
  • progress timely outpatient services for people with suspected gynaecological cancer
  • consider developing clinical practice guidelines for the management of cervical cancer in Ireland
  • progress the centralisation of gynaecological cancer surgery and treatment services
  • support access to survivorship and psycho-oncology services.

5. Partnerships and advocacy

We will promote a whole-of-society approach to cervical cancer prevention and treatment.

We aim to:

  • work with advocacy organisations, local networks, patient partners and other organisations in Ireland and internationally
  • work with our partners to improve access to services and make sure no one is left behind.

6. Communications

We will provide clear and accessible communication to help people make informed decisions about HPV vaccination, cervical screening and treatment.

We aim to:

  • continue to provide evidence-based public information campaigns about the HPV vaccine
  • look for opportunities to provide more accessible information
  • explore innovative digital approaches to improve communications
  • raise awareness of cervical cancer symptoms and encourage people to get help quickly
  • work with communities to understand their needs and develop appropriate targeted approaches.

7. Workforce and education

We will support a skilled workforce to deliver services that meet the needs of everyone.

We aim to:

  • review service capacity
  • provide cultural awareness training for key staff
  • look for ways to improve information, support and service delivery in communities
  • support training and development for vaccination staff
  • explore opportunities to enhance specialist training in CervicalCheck, colposcopy and gynaecology units.

8. Research

We will develop a cervical cancer elimination research programme. It will focus on improving equity and involving people in the design of services.

We aim to:

  • develop a research proposal identifying the main areas of research needed to support elimination
  • work with academic institutions to carry out the agreed research programme.

9. Data, monitoring and evaluation

We will improve how healthcare data is brought together to monitor progress towards cervical cancer elimination, with a particular focus on equity.

We aim to:

  • agree on the indicators for a cervical cancer elimination dashboard
  • work with partners to improve how data is presented and reported
  • improve links with partner organisations and improve data quality
  • develop key performance indicators for gynaecological cancer services
  • monitor HPV genotypes in the population
  • use data to track progress towards elimination and identify inequalities
  • develop a framework to monitor and evaluate the action plan.

Implementing the plan

The HSE project team and Cervical Cancer Elimination partnership will lead the implementation of the action plan. They will report to the HSE Chief Clinical Officer and HSE Board.

We will develop a detailed implementation plan, monitor progress and report annually against the WHO and national targets.

We will publish a report about our progress every year.

This is a beta version - your feedback will help us to improve it

Ireland’s Cervical Cancer Elimination Action Plan 2025-2030